Download presentation
Presentation is loading. Please wait.
Published byMatilda Wiggins Modified over 9 years ago
1
Trends in Prescribing of and Spending on Digoxin in General Practice in England © Copyright NHSBSA 2009
2
Trends in Prescribing of Thiazides and Related Diuretics in General Practice in England © Copyright NHSBSA 2009
3
Trends in Spending on Thiazides and Related Diuretics in General Practice in England © Copyright NHSBSA 2009
4
Trends in Prescribing of Bendroflumethiazide Tabs/Caps in General Practice in England © Copyright NHSBSA 2009
5
Trends in Prescribing of Spironolactone Caps/Tabs in General Practice in England © Copyright NHSBSA 2009
6
Trends in Prescribing of Potassium-sparing Diuretics in General Practice in England © Copyright NHSBSA 2009
7
Trends in Spending on Potassium-sparing Diuretics in General Practice in England © Copyright NHSBSA 2009
8
Trends in Prescribing of Potassium-sparing Diuretics with Other Diuretics in General Practice in England © Copyright NHSBSA 2009
9
Trends in Spending on Potassium-sparing Diuretics with Other Diuretics in General Practice in England © Copyright NHSBSA 2009
10
Trends in Prescribing of and Spending on Amiodarone in General Practice in England © Copyright NHSBSA 2009
11
Trends in Prescribing of Beta-adrenoceptor Blocking Drugs (including Combinations) in General Practice in England © Copyright NHSBSA 2009
12
Trends in Spending on Beta-adrenoceptor Blocking Drugs (including Combinations) in General Practice in England © Copyright NHSBSA 2009
13
Trends in Prescribing of Alpha-adrenoceptor Blocking Drugs in General Practice in England © Copyright NHSBSA 2009
14
Trends in Spending on Alpha-adrenoceptor Blocking Drugs in General Practice in England © Copyright NHSBSA 2009
15
% Ratio of Prescribing of ACE Inhibitors vs Angiotensin-II Receptor Antagonists © Copyright NHSBSA 2009
16
% Ratio of Spending on ACE Inhibitors vs Angiotensin-II Receptor Antagonists © Copyright NHSBSA 2009
17
Trends in Prescribing of ACE Inhibitors (including combinations) in General Practice in England © Copyright NHSBSA 2009
18
Trends in Spending on ACE Inhibitors (including combinations) in General Practice in England © Copyright NHSBSA 2009
19
Trends in Prescribing of Angiotensin-II Receptor Antagonists (including combinations) in General Practice in England © Copyright NHSBSA 2009
20
Trends in Spending on Angiotensin-II Receptor Antagonists (including combinations) in General Practice in England © Copyright NHSBSA 2009
21
Trends in Prescribing of Nitrates in General Practice in England © Copyright NHSBSA 2009
22
Trends in Spending on Nitrates in General Practice in England © Copyright NHSBSA 2009
23
Trends in Prescribing of Calcium-channel Blockers in General Practice in England © Copyright NHSBSA 2009
24
Trends in Spending on Calcium-channel Blockers in General Practice in England © Copyright NHSBSA 2009
25
Trends in Prescribing of and Spending on Nicorandil in General Practice in England © Copyright NHSBSA 2009
26
Trends in Prescribing of Peripheral Vasodilators in General Practice in England © Copyright NHSBSA 2009
27
Trends in Spending on Peripheral Vasodilators in General Practice in England © Copyright NHSBSA 2009
28
Trends in Prescribing of and Spending on Warfarin in General Practice in England © Copyright NHSBSA 2009
29
Trends in Prescribing of Antiplatelet Drugs in General Practice in England © Copyright NHSBSA 2009
30
Trends in Spending on Antiplatelet Drugs in General Practice in England © Copyright NHSBSA 2009
31
Trends in Prescribing of Aspirin BNF 2.9 (E/C Tablets vs Other Formulations) in General Practice in England © Copyright NHSBSA 2009
32
Trends in Spending on Aspirin BNF 2.9 (E/C Tablets vs Other Formulations) in General Practice in England © Copyright NHSBSA 2009
33
Trends in Prescribing of Lipid-regulating Drugs (excluding Statins) in General Practice in England © Copyright NHSBSA 2009
34
Trends in Spending on Lipid-regulating Drugs (excluding Statins) in General Practice in England © Copyright NHSBSA 2009
35
Trends in Prescribing of and Spending on Ezetimibe in General Practice in England © Copyright NHSBSA 2009
36
Trends in Prescribing of Fibrates in General Practice in England © Copyright NHSBSA 2009
37
Trends in Spending on Fibrates in General Practice in England © Copyright NHSBSA 2009
38
Trends in Prescribing of Nicotinic Acid Group Drugs in General Practice in England © Copyright NHSBSA 2009
39
Trends in Spending on Nicotinic Acid Group Drugs in General Practice in England © Copyright NHSBSA 2009
40
Trends in Prescribing of Statins in General Practice in England © Copyright NHSBSA 2009
41
Trends in Spending on Statins in General Practice in England © Copyright NHSBSA 2009
42
Trends in Prescribing of Atorvastatin Tabs by Strength in General Practice in England © Copyright NHSBSA 2009
43
Trends in Spending on Atorvastatin Tabs by Strength in General Practice in England © Copyright NHSBSA 2009
44
Trends in Prescribing of Simvastatin Tabs by Strength in General Practice in England © Copyright NHSBSA 2009
45
Trends in Spending on Simvastatin Tabs by Strength in General Practice in England © Copyright NHSBSA 2009
46
Trends in Prescribing of Rosuvastatin by Strength in General Practice in England © Copyright NHSBSA 2009
47
Trends in Spending on Rosuvastatin by Strength in General Practice in England © Copyright NHSBSA 2009
48
Trends in Prescribing of and Spending on Inegy® in General Practice in England © Copyright NHSBSA 2009
49
% Ratio of Prescribing of High Strength Statins (Atorvastatin 40mg / 80mg, Rosuvastatin 20mg / 40mg, Simvastatin 80mg and Inegy®) vs All Other Statins in General Practice in England © Copyright NHSBSA 2009
50
% Ratio of Spending on High Strength Statins (Atorvastatin 40mg / 80mg, Rosuvastatin 20mg / 40mg, Simvastatin 80mg and Inegy®) vs All Other Statins in General Practice in England © Copyright NHSBSA 2009
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.